يحاول ذهب - حر
CELEBRATING WOMANHOOD ON EQUAL NOTE
March 2020
|BioSpectrum Asia
As nations around the world celebrate International Women’s Day on March 8, with the theme #EachforEqual, the number of companies that have had women in a leadership role continues to expand. But the list is still relatively short, and even when women have made it to power, they have rarely led for a long time. Globally women at leadership position are very less and only 4.9 per cent of Fortune 500 companies have women at leadership position.
Women are still vastly underrepresented in the science fields, even today. There’s a lack of diverse perspectives and voices creating the next life-changing technologies in our societies – a huge missed opportunity. “There are probably many reasons for this. Part of it could be social pressures, but we think a big reason for this is a lack of role models for the young to follow,” says Dr. Low Yen Ling, Divisional Vice President of Scientific & Medical Affairs, Abbott.
At Abbott, Dr. Low Yen Ling adds “advancing the role of women is important to our business and to the organizations and communities we work with around the world. We value diversity and there are initiatives in place such as Abbott’s Women Leaders in Action (WLA) whose mission is to develop women to excel in the organization and support them to increasing levels of leadership.”
In the Clinical Research Organisation (CRO) industry, women tend to dominate entry-level positions, but numbers decline at more senior and executive levels. Family obligations are practical hurdles for women and often take priority over a professional career – indeed culturally in Asia women take on more family responsibilities than men. In addition, often it’s not easy to successfully transition back to work.
Dr. Yooni Kim, Executive Director, Asia Operations, Novotech, Seoul, South Korea says “I think it’s improving. More healthcare companies are focusing on how they can support women and keeping them with the company. Flexible work arrangements is one solution that help women employees manage their lives.” Novotech encourages its people to engage in flexible working practices across all its Asia locations. Both men and women benefit from this, and Novotech’s supportive parental leave program.
هذه القصة من طبعة March 2020 من BioSpectrum Asia.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من BioSpectrum Asia
BioSpectrum Asia
Alphamab Oncology appoints Fei Wang as Chief Financial Officer
Hong Kong-based Alphamab Oncology has announced the appointment of Fei Wang as the Chief Financial Officer (CFO).
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
CarbGeM inks MoU with DSS Imagetech to expand AI business in Indian market
DSS Imagetech, a leading player in medical and research imaging equipment, has announced the signing of a Memorandum of Understanding (MoU) with Japan-based CarbGeM Inc., a developer of artificial intelligence (AI)-powered life science solutions to expand its AI business in the Indian market.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
PHCbi introduces LiCellGrow Cell Expansion System
PHC Corporation's Biomedical Division, a global provider of laboratory sample storage and cell cultivation solutions and subsidiary of Japan's PHC Holdings Corporation, has announced the launch of its new cell expansion system LiCellGrow for research use in Japan and other select countries worldwide.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
CitiusTech appoints Dhaval Shah as Chief Business Officer - MedTech & Life Sciences
CitiusTech, a leading provider of healthcare technology services driving digital and AI excellence in India, has appointed Dhaval Shah to Chief Business Officer - MedTech & Life Sciences.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
Thermo Fisher expands immunodiagnostics operations with new distribution centre in Uppsala
Thermo Fisher Scientific Inc. has announced the opening of a new 8,000-square-meter distribution & labeling centre supporting its immunodiagnostics business in Uppsala.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
Harbour BioMed appoints Dr Jenny Xie as Head of Global External Innovation
Harbour BioMed, a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, has announced the appointment of Dr Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
Argo Biopharma ropes in Dr Gena Wang as CFO and CSO
China-based Argo Biopharmaceutical Co., a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, has announced the appointment of Dr Gena Wang as Chief Financial Officer (CFO) and Chief Strategy Officer (CSO), effective March 1, 2026.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
IISc launches "Moonshot" project on brain co-processors supported by Pratiksha Trust
The Indian Institute of Science (IISc), Bengaluru has launched an ambitious \"moonshot\" project to develop brain co-processors that combine neuromorphic hardware and artificial intelligence (AI) algorithms to enhance or restore brain function.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
Korea designs model for accurate and scalable drug-drug interaction prediction
A research team from the School of International Engineering and Science at Jeonbuk National University (JBNU), South Korea, has developed DDINet, a lightweight and scalable model, specifically designed to predict interactions for new, unseen drugs.
1 min
BioSpectrum Asia April 2027
BioSpectrum Asia
Australia-Singapore study advocates role of intranasal vaccine booster against sarbecoviruses
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia, have demonstrated that an intranasal vaccine booster may confer significantly stronger and broader immune responses, and provide robust neutralising antibody and resident T cell responses in the lung and nasal tissues, outperforming conventional mRNA booster vaccination.
1 min
BioSpectrum Asia April 2027
Translate
Change font size
